Quotes & Comments…
“We are all navigating this new normal together. As we lock arms virtually and try to help one another in the ways we can, our vast world suddenly feels a little smaller and a lot more connected. And for that, we are grateful.” – Michael Dell, CEO of Dell
“It’s a very unique environment that none of us have seen before, and there is no playbook for how to react in this environment. We’re writing the script each and every day.” – Brian Cornell, CEO of Target
“The key is to keep the DNA of the business intact so that when we come back out of this incredible, unique situation, we have all the building blocks we started with before to spring right back into business.” – Kevin O’Leary, Entrepreneur and co-star of Shark Tank
FM Broadcast – Summer 2020
Looking Forward
As companies and individuals continue to adapt to the COVID era, it seems that acceptance is a key component of moving forward. As a firm, we are seeing more of our clients acknowledge the dramatic changes to their business environment, which gives the certainty needed to plan for the future once again.
A recent industry-wide survey of executive recruiting firms revealed that, despite devastating metrics in March and April, the number of “opened” or newly-started searches has significantly increased month-over-month from May onwards. The industry is not back to 2019 numbers, and that is perhaps not a realistic expectation, but the steady buildup in activity is a good sign.
As you will see from our recent activity at the bottom of this newsletter, FlemingMartin has mirrored these findings; we have completed a number of searches and kicked off nine new searches over the past couple of months. Another positive metric is that our pipeline of prospective new searches continues to grow, and prospective clients are seeking to target and attract previously unattainable talent.
Even though this may be a challenging time, we continue to push ahead while being mindful of the changed landscape for us all. We hope that you are seeing some positive recent developments in your businesses as well, and we encourage you to share your stories of success.
Keep moving forward!
The FlemingMartin team
Expert Opinions…
Client Snapshot: Global Blood Therapeutics (NASDAQ: GBT)
Global Blood Therapeutics (GBT) is a mission-driven biopharmaceutical company committed to helping underserved patient communities by revolutionizing the treatment of severe blood-based conditions. The Company’s lead product, Voxelotor/Oxbryta, was recently approved by the FDA as a first-of-its-kind treatment for Sickle Cell Disease.
FlemingMartin is proud to be a partner of GBT, having recruited GBT’s Global Head of Total Rewards. You can read the press release along with an article/podcast on GBT’s CEO, Ted Love, here:
FlemingMartin News – Celebrating Jonah Klein’s Five-Year Anniversary
We are proud to celebrate the five-year anniversary of FlemingMartin’s Life Sciences & Healthtech Practice Leader, Jonah Klein. In 2015, Jonah joined FlemingMartin full-time and has since founded and grown our Life Sciences practice to be one of the best on the West Coast.
Jonah has built a reputation as a thought leader and a proven business partner who helps clients navigate the fluid and changing talent landscape in his sector. He puts relationships at the forefront of everything he does, connecting with clients and candidates and proving himself to be a valuable resource to executives nationwide.
We are honored to have Jonah on the team and look forward to the next five years!
– Marty & Fleming
Connecting leaders
Recruiting the best executive talent
Recently Completed Searches
Fastly (NYSE: FSLY)
RAPT Therapeutics (NASDAQ: RAPT)
McGrath RentCorp (NASDAQ: MGRC)
Seek Thermal
Bragg Live Foods (Swander Pace Capital)
Highlighted Current Searches
Private Digital Health Company
- CEO
Public Technology Company
- VP, Total Rewards, People Operations & Analytics
Private Autonomous Vehicle Technology Company
- VP, People
Public Technology Company
- VP, eCommerce
Public Biotechnology Company
- Head of CDx Product Management
Private Biomedical Diagnostics Company
- Vice President, Operations
Private Biomedical Diagnostics Company
- Vice President, Software
Public Biotechnology Company
- Executive Director, Talent Acquisition